FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - FRA:FME - DE0005785802 - Common Stock
41.04 EUR
-0.1 (-0.24%)
Overall FME gets a fundamental rating of 5 out of 10. We evaluated FME against 30 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. FME has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
FME had positive earnings in the past year.
FME had a positive operating cash flow in the past year.
In the past 5 years FME has always been profitable.
Each year in the past 5 years FME had a positive operating cash flow.
1.2 Ratios
FME's Return On Assets of 2.10% is in line compared to the rest of the industry. FME outperforms 50.00% of its industry peers.
FME has a Return On Equity (4.95%) which is in line with its industry peers.
FME has a Return On Invested Capital of 3.84%. This is comparable to the rest of the industry: FME outperforms 46.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 6.66%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FME has a Profit Margin of 3.36%. This is in the better half of the industry: FME outperforms 66.67% of its industry peers.
FME's Profit Margin has declined in the last couple of years.
FME's Operating Margin of 7.15% is fine compared to the rest of the industry. FME outperforms 63.33% of its industry peers.
In the last couple of years the Operating Margin of FME has declined.
With a Gross Margin value of 24.67%, FME perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FME has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for FME has been reduced compared to 5 years ago.
The debt/assets ratio for FME has been reduced compared to a year ago.
2.2 Solvency
FME has an Altman-Z score of 2.17. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.17, FME is in line with its industry, outperforming 53.33% of the companies in the same industry.
FME has a debt to FCF ratio of 5.47. This is a neutral value as FME would need 5.47 years to pay back of all of its debts.
FME's Debt to FCF ratio of 5.47 is fine compared to the rest of the industry. FME outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that FME is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, FME is doing good in the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.17 |
ROIC/WACC0.67
WACC5.72%
2.3 Liquidity
FME has a Current Ratio of 1.44. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
FME has a better Current ratio (1.44) than 70.00% of its industry peers.
FME has a Quick Ratio of 1.08. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
FME has a Quick ratio of 1.08. This is in the better half of the industry: FME outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
FME shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.08%.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
The Revenue has decreased by -0.61% in the past year.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
3.2 Future
Based on estimates for the next years, FME will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.70% on average per year.
The Revenue is expected to grow by 3.96% on average over the next years.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
FME is valuated correctly with a Price/Earnings ratio of 12.75.
80.00% of the companies in the same industry are more expensive than FME, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.28, FME is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.91, the valuation of FME can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 86.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.61, FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.75 | ||
| Fwd PE | 9.91 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FME is on the same level as its industry peers.
66.67% of the companies in the same industry are more expensive than FME, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.95 | ||
| EV/EBITDA | 10.8 |
4.3 Compensation for Growth
FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FME's earnings are expected to grow with 13.44% in the coming years.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.43%.
Compared to an average industry Dividend Yield of 2.55, FME pays a better dividend. On top of this FME pays more dividend than 93.33% of the companies listed in the same industry.
FME's Dividend Yield is a higher than the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.43% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
FME pays out 64.37% of its income as dividend. This is not a sustainable payout ratio.
The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP64.37%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (11/11/2025, 3:22:24 PM)
41.04
-0.1 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.08B
Revenue(TTM)19.34B
Net Income(TTM)656.42M
Analysts65.6
Price Target49.48 (20.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.43% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)14.89%
Max EPS beat(2)27.17%
EPS beat(4)4
Avg EPS beat(4)20.72%
Min EPS beat(4)14.89%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)15.78%
EPS beat(12)10
Avg EPS beat(12)13.92%
EPS beat(16)12
Avg EPS beat(16)10.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.72%
PT rev (3m)-4.31%
EPS NQ rev (1m)7.47%
EPS NQ rev (3m)8.76%
EPS NY rev (1m)0.52%
EPS NY rev (3m)3.82%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.75 | ||
| Fwd PE | 9.91 | ||
| P/S | 1.23 | ||
| P/FCF | 11.95 | ||
| P/OCF | 8.74 | ||
| P/B | 1.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.8 |
EPS(TTM)3.22
EY7.85%
EPS(NY)4.14
Fwd EY10.09%
FCF(TTM)3.43
FCFY8.37%
OCF(TTM)4.69
OCFY11.44%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.69
PEG (5Y)N/A
Graham Number40.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.17 |
F-Score6
WACC5.72%
ROIC/WACC0.67
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y19.09%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 12.75 and the Price/Book (PB) ratio is 1.81.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 64.37%.